Big Pharma's 2009-2013 Patent Cliff: A Comparison of Company-Level Responses and Strategic Recommendations for Pfizer, Inc. and Eli Lilly and Company

Aladin Research Commons

Big Pharma's 2009-2013 Patent Cliff: A Comparison of Company-Level Responses and Strategic Recommendations for Pfizer, Inc. and Eli Lilly and Company

Show simple item record

dc.contributor.author Jardines, Benjamin
dc.date.accessioned 2011-03-04T21:06:54Z
dc.date.available 2011-03-04T21:06:54Z
dc.date.created 2010-04
dc.date.issued 2011-03-04T21:06:54Z
dc.identifier.uri http://hdl.handle.net/1961/9359
dc.language.iso en_US en
dc.rights Copyright 2010, Benjamin Jardines. Attribution only; Non-commercial uses only; No derivative works en
dc.subject.other Drug Companies en
dc.subject.other Pfizer en
dc.subject.other Eli Lilly en
dc.subject.other business en
dc.title Big Pharma's 2009-2013 Patent Cliff: A Comparison of Company-Level Responses and Strategic Recommendations for Pfizer, Inc. and Eli Lilly and Company en
dc.type Other en


Files in this item

Files Size Format View
Jardines, Ben - Spring '10 (P).pdf 808.5Kb PDF View/Open

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics